Top News

Feb 13, 2018
By BioPharm International Editors
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
Feb 01, 2018
The President described US drug costs as unfair and stated that prices will come down.
Jan 30, 2018
By BioPharm International Editors
The acquisition will strengthen Sanofi's R&D strategy and expands its franchise for rare blood disorders.
Jan 24, 2018
By BioPharm International Editors
The acquisition would boost Sanofi's position in hematology and specialty medicines.
Jan 23, 2018
By BioPharm International Editors
The latest continuing resolution funds the government for three weeks.
Jan 22, 2018
By BioPharm International Editors
Non-essential activities and new regulatory submissions are on hold until a federal government funding agreement is reached.
Jan 19, 2018
By BioPharm International Editors
Frustrated with chronic shortages and high costs, hospitals form their own generic drug company.
Jan 05, 2018
By BioPharm International Editors
FDA Commissioner Gottlieb expects that the saline and amino acid drug shortages from Puerto Rican manufacturing facilities will improve in the early part of 2018.
Dec 20, 2017
New tax legislation may result in savings for biopharma companies.
Dec 18, 2017
By BioPharm International Editors
The US Court of Appeals for the Federal Circuit has decided in favor of Novartis’ Sandoz in rendering the opinion that Amgen cannot use state laws to prohibit or delay the marketing of biosimilars.
native1_300x100
lorem ipsum